Withers D J, Coppock H A, Seufferlein T, Smith D M, Bloom S R, Rozengurt E
Imperial Cancer Research Fund, London, UK.
FEBS Lett. 1996 Jan 2;378(1):83-7. doi: 10.1016/0014-5793(95)01427-6.
Our results demonstrate that the novel vasoactive regulatory peptide adrenomedullin is a potent mitogen for Swiss 3T3 cells. Acting via a specific adrenomedullin receptor, it stimulates a dose-dependent increase in DNA synthesis in synergy with insulin. Additionally, adrenomedullin stimulates further progression through the cell cycle resulting in cell proliferation, an effect that was further enhanced by the presence of insulin. Adrenomedullin rapidly induces accumulation of intracellular cAMP but does not stimulate an increase in intracellular Ca2+, activation of protein kinase C, or tyrosine phosphorylation of intracellular substrates. Adrenomedullin-stimulated mitogenesis is markedly enhanced in Swiss 3T3 cells stably transfected with a constitutively activated Gs alpha, which are highly sensitive to agents that elevate cAMP, and is inhibited by the PKA inhibitor H-89. Adrenomedullin is, thus, identified as a novel mitogenic regulatory peptide acting via cAMP.
我们的研究结果表明,新型血管活性调节肽肾上腺髓质素是瑞士3T3细胞的一种有效促有丝分裂原。它通过特定的肾上腺髓质素受体发挥作用,与胰岛素协同刺激DNA合成呈剂量依赖性增加。此外,肾上腺髓质素刺激细胞周期进一步进展,导致细胞增殖,胰岛素的存在进一步增强了这一效应。肾上腺髓质素迅速诱导细胞内cAMP积累,但不刺激细胞内Ca2+增加、蛋白激酶C激活或细胞内底物的酪氨酸磷酸化。在稳定转染组成型激活的Gsα的瑞士3T3细胞中,肾上腺髓质素刺激的有丝分裂明显增强,这些细胞对升高cAMP的试剂高度敏感,并被PKA抑制剂H-89抑制。因此,肾上腺髓质素被确定为一种通过cAMP发挥作用的新型有丝分裂调节肽。